Identification of hub genes for the diagnosis associated with heart failure using multiple cell death patterns

Hua-Jing Yuan1, Hui Yu1, Yi-Ding Yu1

  • 1First School of Clinical Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.

ESC Heart Failure
|April 10, 2025
PubMed

Insights

This study identified DHRS11 and LRKK2 as key genes in heart failure (HF) related to programmed cell death (PCD). These findings offer new diagnostic biomarkers and insights into HF pathogenesis.

Area of Science:

  • Genomics
  • Molecular Biology
  • Cardiovascular Research

Background:

  • Heart failure (HF) is a global health concern with complex pathological mechanisms.
  • Programmed cell death (PCD) significantly contributes to the development and progression of HF.

Purpose of the Study:

  • To identify key genes associated with HF, specifically those linked to PCD.
  • To develop a diagnostic model for HF based on identified hub genes.
  • To elucidate the molecular mechanisms and immune landscape of HF.

Main Methods:

  • Utilized bioinformatics and machine learning on HF gene expression datasets from the GEO database.
  • Performed functional enrichment analysis to understand gene ontology and pathways.
  • Conducted immune infiltration analysis to assess immune cell expression in relation to hub genes.

Main Results:

  • Identified 95 key HF genes primarily involved in inflammation and immunomodulation.
  • DHRS11 and LRKK2 were identified as PCD-associated HF hub genes.
  • Developed a diagnostic model with effective value, confirming hub genes as HF biomarkers.
  • Observed significant immune imbalance in T-cell populations, monocytes, and M2 macrophages in HF.

Conclusions:

  • DHRS11 and LRKK2 are identified as crucial hub genes in HF associated with PCD.
  • The developed HF diagnostic model and immune infiltration insights provide novel perspectives on HF molecular mechanisms.
  • This research offers potential advancements in HF diagnosis and treatment strategies.
Abstract